The structure of the N-terminal actin-binding domain of human dystrophin and how mutations in this domain may cause Duchenne or Becker muscular dystrophy.

BACKGROUND Dystrophin is an essential component of skeletal muscle cells. Its N-terminal domain binds to F-actin and its C terminus binds to the dystrophin-associated glycoprotein (DAG) complex in the membrane. Dystrophin is therefore thought to serve as a link from the actin-based cytoskeleton of the muscle cell through the plasma membrane to the extracellular matrix. Pathogenic mutations in dystrophin result in Duchenne or Becker muscular dystrophy. RESULTS The crystal structure of the dystrophin actin-binding domain (ABD) has been determined at 2.6 A resolution. The structure is an antiparallel dimer of two ABDs each comprising two calponin homology domains (CH1 and CH2) that are linked by a central alpha helix. The CH domains are both alpha-helical globular folds. Comparisons with the structures of utrophin and fimbrin ABDs reveal that the conformations of the individual CH domains are very similar to those of dystrophin but that the arrangement of the two CH domains within the ABD is altered. The dystrophin dimer reveals a change of 72 degrees in the orientation of one pair of CH1 and CH2 domains (from different monomers) relative to the other pair when compared with the utrophin dimer. The dystrophin monomer is more elongated than the fimbrin ABD. CONCLUSIONS The dystrophin ABD structure reveals a previously uncharacterised arrangement of the CH domains within the ABD. This observation has implications for the mechanism of actin binding by dystrophin and related proteins. Examining the position of three pathogenic missense mutations within the structure suggests that they exert their effects through misfolding of the ABD, rather than through disruption of the binding to F-actin.

[1]  M. Saraste,et al.  Structural comparisons of calponin homology domains: implications for actin binding. , 1998, Structure.

[2]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[3]  M Bobrow,et al.  Searching for the 1 in 2,400,000: A review of dystrophin gene point mutations , 1994, Human mutation.

[4]  G J Barton,et al.  ALSCRIPT: a tool to format multiple sequence alignments. , 1993, Protein engineering.

[5]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[6]  S. Winder,et al.  Crystal structure of the actin-binding region of utrophin reveals a head-to-tail dimer. , 1999, Structure.

[7]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[8]  M. Way,et al.  Expression of the N‐terminal domain of dystrophin in E. coli and demonstration of binding to F‐actin , 1992, FEBS letters.

[9]  J. Thornton,et al.  Helix geometry in proteins. , 1988, Journal of molecular biology.

[10]  A. Monaco,et al.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene , 1986, Nature.

[11]  G J Kleywegt,et al.  Phi/psi-chology: Ramachandran revisited. , 1996, Structure.

[12]  K. Campbell,et al.  Association of dystrophin and an integral membrane glycoprotein , 1989, Nature.

[13]  J. Mendell,et al.  A missense mutation in the dystrophin gene in a Duchenne muscular dystrophy patient , 1993, Nature Genetics.

[14]  A. Adams,et al.  Genetic analysis of the fimbrin-actin binding interaction in Saccharomyces cerevisiae. , 1995, Genetics.

[15]  J. Ervasti,et al.  Utrophin Lacks the Rod Domain Actin Binding Activity of Dystrophin* , 1999, The Journal of Biological Chemistry.

[16]  D. DeRosier,et al.  Evidence for a Conformational Change in Actin Induced by Fimbrin (N375) Binding , 1997, The Journal of cell biology.

[17]  K. Davies,et al.  Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene , 1996, Nature.

[18]  R M Esnouf,et al.  An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. , 1997, Journal of molecular graphics & modelling.

[19]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[20]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[21]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[22]  A. McGough.  F-actin-binding proteins. , 1998, Current opinion in structural biology.

[23]  T. Gibson,et al.  Dystrophin and utrophin: the missing links! , 1995, FEBS letters.

[24]  R. Heilig,et al.  Isolated dystrophin molecules as seen by electron microscopy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  F. Walsh,et al.  Co-localization and molecular association of dystrophin with laminin at the surface of mouse and human myotubes. , 1992, Journal of cell science.

[26]  P. Fitzgerald,et al.  Molecular replacement , 1992 .

[27]  J. Ervasti,et al.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin , 1993, The Journal of cell biology.

[28]  Susan C. Brown,et al.  Dystrophin : gene, protein, and cell biology , 1997 .

[29]  S. Vishveshwara,et al.  Geometry of proline-containing alpha-helices in proteins. , 2009, International journal of peptide and protein research.

[30]  Hideko Yamamoto,et al.  Glycoprotein‐binding site of dystrophin is confined to the cysteine‐rich domain and the first half of the carboxy‐terminal domain , 1992, FEBS letters.

[31]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[32]  S. Almo,et al.  The modular structure of actin-regulatory proteins. , 1998, Current opinion in cell biology.

[33]  J. Mandel,et al.  Two hot spots of recombination in the DMD gene correlate with the deletion prone regions. , 1992, Human molecular genetics.

[34]  C. van Broeckhoven,et al.  Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. , 1989, American journal of human genetics.

[35]  J. Ervasti,et al.  A new model for the interaction of dystrophin with F-actin , 1996, The Journal of cell biology.

[36]  T. Stradal,et al.  CH domains revisited , 1998, FEBS letters.

[37]  R. Saiki,et al.  A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. , 1988, Nucleic acids research.

[38]  M G Rossmann,et al.  The locked rotation function. , 1990, Acta crystallographica. Section A, Foundations of crystallography.

[39]  A. Moir,et al.  The interaction of actin with dystrophin , 1990, FEBS letters.

[40]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[41]  M. Saraste,et al.  Crystal structure of a calponin homology domain , 1997, Nature Structural Biology.

[42]  L. Kunkel,et al.  Dystrobrevin and dystrophin: an interaction through coiled-coil motifs. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Paul T Matsudalra.  Modular organization of actin crosslinking proteins. , 1991 .

[44]  R. Hammonds.  Protein sequence of DMD gene is related to actin-binding domain of α-actinin , 1987, Cell.

[45]  D. DeRosier,et al.  Determination of the alpha-actinin-binding site on actin filaments by cryoelectron microscopy and image analysis , 1994, The Journal of cell biology.

[46]  D. Branton,et al.  Sequence similarity of the amino-terminal domain of Drosophila beta spectrin to alpha actinin and dystrophin , 1989, The Journal of cell biology.

[47]  S. Jones,et al.  Principles of protein-protein interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Koenig,et al.  Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.

[49]  J. Ervasti,et al.  A Cluster of Basic Repeats in the Dystrophin Rod Domain Binds F-actin through an Electrostatic Interaction* , 1998, The Journal of Biological Chemistry.

[50]  F. Muntoni,et al.  Deletions in the 5' region of dystrophin and resulting phenotypes. , 1994, Journal of medical genetics.

[51]  Niels Volkmann,et al.  A protein disulfide oxidoreductase from the archaeon Pyrococcus furiosus contains two thioredoxin fold units , 1998, Nature Structural Biology.

[52]  S. Winder,et al.  The 2.0 A structure of the second calponin homology domain from the actin-binding region of the dystrophin homologue utrophin. , 1999, Journal of molecular biology.

[53]  L. Kunkel,et al.  In vitro expressed dystrophin fragments do not associate with each other , 1997, FEBS letters.

[54]  C. Moores,et al.  Structure of the utrophin actin-binding domain bound to F-actin reveals binding by an induced fit mechanism. , 2000, Journal of molecular biology.

[55]  K. Corrado,et al.  Deletion analysis of the dystrophin‐actin binding domain , 1994, FEBS letters.

[56]  A. Monaco,et al.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein , 1988, Cell.

[57]  A. Fedorov,et al.  The structure of an actin-crosslinking domain from human fimbrin , 1997, Nature Structural Biology.

[58]  H Sugita,et al.  Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. , 1991, American journal of human genetics.

[59]  A. Moir,et al.  Binding sites involved in the interaction of actin with the N‐terminal region of dystrophin , 1992, FEBS letters.

[60]  Axel T. Brunger,et al.  X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .

[61]  J. Ervasti,et al.  Dystrophin-Glycoprotein Complex Is Monomeric and Stabilizes Actin Filaments in Vitro through a Lateral Association* , 1997, The Journal of Biological Chemistry.

[62]  M. Saraste,et al.  Does Vav bind to F‐actin through a CH domain? , 1995, FEBS letters.